We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surveillance of Summer Febrile Syndromes of Viral Origin in South of France

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00842166
First Posted: February 12, 2009
Last Update Posted: August 29, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille
  Purpose
The aim is to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France in order to better understand the role of known vector-borne viruses such as Toscana virus, West Nile virus during seasonal activity of the arthropod vector. In each of the four cities, a network of general practitioners will be associated in the project to recruit patients who are not hospitalized. The combined involvement of infectious disease specialists and general practitioner will augment the range of patients (mild disease and sever cases) in the study.

Condition Intervention
Summer Febrile Syndromes of Viral Origin Other: BLOOD DRAW

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by Assistance Publique Hopitaux De Marseille:

Primary Outcome Measures:
  • to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France [ Time Frame: 3 years ]

Secondary Outcome Measures:
  • Identification and characterization of emergent viruses responsible for estival fever in the south of France [ Time Frame: 3years ]

Enrollment: 90
Study Start Date: February 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: BLOOD DRAW
    specific interview, sequential blood collection to allow virus isolation, molecular and serological diagnostics in patients
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Old: equal to or higher than 5 years Living in the south of France, without voyage abroad in the 2 weeks preceding inclusion Presenting a fever or a syndrome pseudogripal since less than 7 days without diagnostic orientation nor infectious pathology of body,
  • Affiliated with a mode of social security
  • After obtaining free and informed of the written assent

Exclusion Criteria:

  • Subject whose adhesion with the protocol is improbable according to the investigator
  • Expectant mother
  • Subject taking part in another clinical trial or in period of exclusion of a preceding clinical trial infectious
  • Pathology of body requiring a specific treatment
  • Discovered after inclusion d' a pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00842166


Locations
France
Service des Maladies Infectieuses et Tropicales de l'Hôpital Nord, AP-HM
Marseille, France
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Principal Investigator: REMI CHARREL Assistance Publique Hopitaux De Marseille
  More Information

Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT00842166     History of Changes
Other Study ID Numbers: 2008 19
2008-A00793-52
First Submitted: February 11, 2009
First Posted: February 12, 2009
Last Update Posted: August 29, 2014
Last Verified: August 2014

Additional relevant MeSH terms:
Syndrome
Fever
Disease
Pathologic Processes
Body Temperature Changes
Signs and Symptoms